cns.jpg (2811 bytes)

Subscription

Reprints

Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates


Neva Press, Inc. 2005


CNS Drug Reviews

Table of Contents

Volume 7, No. 3

New Drugs
249 A Review of the Pharmacological and Clinical Profile of Mirtazapine
Sami A. K. Anttila and Esa V. J. Leinonen
[Abstract] [Article] [Single Reprint]
265 Pharmacology of the Atypical Antipsychotic Remoxipride, a Dopamine D2 Receptor Antagonist
Roser Nadal
[Abstract] [Article] [Single Reprint]
283 Fluvoxamine as an Adjunctive Agent in Schizophrenia
Henry Silver
[Abstract] [Article] [Single Reprint] 
305   Adrogolide HCl (ABT-431; DAS-431), a Prodrug of the Dopamine D1 Receptor Agonist, A-86929:  Preclinical Pharmacology and Clinical Data
William J. Giardina and Michael Williams
[Abstract] [Article] [Single Reprint]
    New Concepts
317   Antiaging Compounds:  (-)Deprenyl (Selegiline) and (-)1-(Benzofuran-2-yl)-2- propylaminopentane, [(-)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain
J. Knoll
[Abstract] [Article] [Single Reprint]
Meeting Report
346 Alzheimer's Disease, Cancer and the Search for a Better Aspirin.  Postgraduate Course at Mount Sinai School of Medicine.  New York, NY.  June 22-23, 2001.
Alexander Scriabine
[Article] [Single Reprint]